Ipivivint
Based on 1 publication(s) in Google Scholar
Ipivivint (Compound 38) is an orally active and potent CDC-like kinase (CLK) inhibitor with EC50 of 1 nM and 7 nM for CLK2 (human) and CLK3 (human), respectively. Ipivivint also inhibits the Wnt pathway (EC50=13 nM) and tyrosine phosphorylation-regulated kinase 1A (human) (EC50=5 nM).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.95%
- CAS 番号: 1481617-15-5
- 分子式: C26H21FN8
- 分子量:464.50
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
MedChemExpress(MCE)の使用を引用している文献 Ipivivint
More
生物活性
製品説明
IC50 & Target
[1]|
CDK2 1 nM (EC50) |
CDK3 7 nM (EC50) |
体外実験
-
Cell Line:SW480 cells
-
Concentration:0.01~10 μM
-
Incubation Time:1 hour
-
Result:Potently inhibited SRSF5/6 phosphorylation.
-
Cell Line:SW480 cells
-
Concentration:0.01~10 μM
-
Incubation Time:0.03 μM~3 μM
-
Result:Induced apoptosis.
-
Cell Line:HEK-293T cells
-
Concentration:0.3~3 μM
-
Incubation Time:1 hour
-
Result:Inhibited Wnt/β-catenin signaling induced by Wnt3a.
-
Cell Line:SW480 cells
-
Concentration:0.3~10 μM
-
Incubation Time:6 hours
-
Result:Increased nuclear speckle enlargement.
体内実験
-
Animal Model:Foxn1 mice[1]
-
Dosage:25 mg/kg
-
Administration:P.o.
-
Result:Potently inhibited tumor SRSF6 phosphorylation.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 1481617-15-5
-
性状 Solid
-
分子量 464.50
-
分子式 C26H21FN8
-
Color Off-white to light yellow
-
SMILES
CN(C)CC1=CC(C2=CN=C(NN=C3C(N4)=NC5=C4C(C6=CC(F)=CC=C6)=CN=C5)C3=C2)=CN=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Bioorg Med Chem
Identification of a novel Aurora B inhibitor using the AI-driven drug screening and docking-based traditional screening. [Abstract]2025 Sep 27:131:118423. PMID: 41033076
溶剤 & 溶解度
体外:
DMSO : 3.33 mg/mL (7.17 mM; ultrasonic and warming and heat to 80°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.1529 mL | 10.7643 mL | 21.5285 mL | 53.8213 mL |
| 5 mM | 0.4306 mL | 2.1529 mL | 4.3057 mL | 10.7643 mL |